stockrowLifeStance Health Group, Inc.
LFST Healthcare Medical Care Facilities
LifeStance Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 13.9% from fiscal 2024.
- Revenue
- +25.3%
- EPS
- +2,042.9%
- Free cash flow
- +31.6%
- Total debt
- −5.15%
Quarter to September 2026, against a year earlier
Follow LFST
Alert me
LifeStance Health Group, Inc. (LFST) EPS (diluted)
LifeStance Health Group, Inc.'s EPS (diluted) for fiscal 2025 was $0.02, compared with −$0.15 in fiscal 2024. Over the twelve months to 30 September 2026 it was $0.19. Over the past ten years it has ranged from −$1.05 (fiscal 2021) to $0.02 (fiscal 2025) — the current reading is the highest in ten years. EPS (diluted) has risen for 4 consecutive fiscal years. LifeStance Health Group, Inc. ranks 26th of 48 Medical Care Facilities companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $0.02 | — |
| FY2024 | −$0.15 | — |
| FY2023 | −$0.51 | — |
| FY2022 | −$0.61 | — |
| FY2021 | −$1.05 | — |
| FY2020 | −$0.04 | — |
| FY2019 | −$0.16 | — |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Sep 2026 | $0.06 | 0.00% |
| Jun 2026 | $0.06 | 50.00% |
| Mar 2026 | $0.04 | 33.33% |
| Dec 2025 | $0.03 | 971.43% |
| 22 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| CHE Chemed Corporation compare | $20.90 |
| NHC National HealthCare Corporation compare | $7.24 |
| PACS PACS Group, Inc. compare | $1.77 |
| CON Concentra Group Holdings Parent, Inc. compare | $1.69 |
| OPCH Option Care Health, Inc. compare | $1.39 |
| AVAH Aveanna Healthcare Holdings Inc. compare | $1.23 |
| LFST LifeStance Health Group, Inc. | $0.19 |
| SGRY Surgery Partners, Inc. compare | −$0.70 |
| ACHC Acadia Healthcare Company, Inc. compare | −$12.47 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on LFST
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement